References

Ach RA, Wang H, Curry B. Measuring microRNAs: comparisons of microarray and quantitative PCR measurements, and of different total RNA prep methods. BMC Biotechnol. 2008;8:69. doi: 10.1186/1472-6750-8-69.

Andreasen D, Fog JU, Biggs W, et al. Improved microRNA quantification in total RNA from clinical samples. Methods. 2010;50:S6-9. doi:10.1016/j.ymeth.2010.01.006.

Arroyo JD, Chevillet JR, Kroh EM, et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A. 2011;108:5003-8. doi:10.1073/pnas.1019055108.

Ballantyne KN, Van Oorschot RA, Mitchell RJ. Locked nucleic acids in PCR primers increase sensitivity and performance. Genomics. 2008;91:301-5. doi:10.1016/j.ygeno.2007.10.016.

Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136:215-33. doi:10.1016/j.cell.2009.01.002.

Bertoia ML, Bertrand KA, Sawyer SJ, et al. Reproducibility of circulating microRNAs in stored plasma samples. PLoS One. 2015;10:e0136665. doi:10.1371/journal.pone.0136665.

Bryant RJ, Pawlowski T, Catto JW, et al. Changes in circulating microRNA levels associated with prostate cancer. Br J Cancer. 2012;106:768-74. doi:10.1038/bjc.2011.595.

Castoldi M, Schmidt S, Benes V, et al. miChip: an array-based method for microRNA expression profiling using locked nucleic acid capture probes. Nat Protoc. 2008;3:321-9. doi:10.1038/ nprot.2008.4.

Castoldi M, Schmidt S, Benes V, et al. A sensitive array for microRNA expression profiling (miChip) based on locked nucleic acids (LNA). RNA. 2006;12:913-20. doi:10.1016/j. cardfail.2016.04.016.

Cavarretta E, Chiariello GA, Condorelli G. Platelets, endothelium, and circulating microRNA-126 as a prognostic biomarker in cardiovascular diseases: per aspirin ad astra. Eur Heart J. 2013;34:3400-2. doi:10.1093/eurheartj/eht032.

Chen C, Ridzon DA, Broomer AJ, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 2005;33:e179.

Chen J, Lozach J, Garcia EW, et al. Highly sensitive and specific microRNA expression profiling using BeadArray technology. Nucleic Acids Res. 2008;36:e87. doi:10.1093/nar/gkn387.

Chen Y, Gelfond JA, Mcmanus LM, et al. Reproducibility of quantitative RT-PCR array in miRNA expression profiling and comparison with microarray analysis. BMC Genomics. 2009;10:407. doi: 10.1186/1471-2164-10-407.

Cheng HH, Yi HS, Kim Y, et al. Plasma processing conditions substantially influence circulating microRNA biomarker levels. PLoS One. 2013;8:e64795. doi:10.1371/journal.pone.0064795.

Chevillet JR, Kang Q, Ruf IK, et al. Quantitative and stoichiometric analysis of the microRNA content of exosomes. Proc Natl Acad Sci USA. 2014;111:14888-93. doi:10.1073/ pnas.1408301111.

Creighton CJ, Reid JG, Gunaratne PH. Expression profiling of microRNAs by deep sequencing. Brief Bioinform. 2009;10:490-7. doi:10.1093/bib/bbp019.

Cui W, Ma J, Wang Y, et al. Plasma miRNA as biomarkers for assessment of total-body radiation exposure dosimetry. PLoS One. 2011;6:e22988. doi:10.1371/journal.pone.0022988.

D’alessandra Y, Devanna P, Limana F, et al. Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur Heart J. 2010;31:2765-73. doi:10.1093/eurheartj/ehq167.

De Boer HC, Van Solingen C, Prins J, et al. Aspirin treatment hampers the use of plasma microRNA-126 as a biomarker for the progression of vascular disease. Eur Heart J. 2013;34:3451-7. doi:10.1093/eurheartj/eht007.

Duttagupta R, Jiang R, Gollub J, et al. Impact of cellular miRNAs on circulating miRNA biomarker signatures. PLoS One. 2011;6:e20769. doi:10.1371/journal.pone.0020769.

Ecker JR, Bickmore WA, Barroso I, et al. Genomics: ENCODE explained. Nature. 2012;489:52-5. doi:10.1038/489052a.

Engelhardt S. Small RNA biomarkers come of age. J Am Coll Cardiol. 2012;60:300-3. doi:10.1016/j.jacc.2012.04.018.

Fichtlscherer S, De Rosa S, Fox H, et al. Circulating microRNAs in patients with coronary artery disease. Circ Res. 2010;107:677-84. doi:10.1161/CIRCRESAHA.109.215566.

Garcia ME, Blanco JL, Caballero J, et al. Anticoagulants interfere with PCR used to diagnose invasive aspergillosis. J Clin Microbiol. 2002;40:1567-8.

Git A, Dvinge H, Salmon-Divon M, et al. Systematic comparison of microarray profiling, realtime PCR, and next-generation sequencing technologies for measuring differential microRNA expression. RNA. 2010;16:991-1006. doi:10.1261/rna.1947110.

Goren Y, Kushnir M, Zafrir B, et al. Serum levels of microRNAs in patients with heart failure. Eur J Heart Fail. 2012;14:147-54. doi:10.1093/eurjhf/hfr155.

Hergenreider E, Heydt S, Treguer K, et al. Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat Cell Biol. 2012;14:249-56. doi:10.1038/ ncb2441.

Hindson CM, Chevillet JR, Briggs HA, et al. Absolute quantification by droplet digital PCR versus analog real-time PCR. Nat Methods. 2013;10:1003-5. doi:10.1038/nmeth.2633.

Indolfi C, Curcio A. Stargazing microRNA maps a new miR-21 star for cardiac hypertrophy. J Clin Invest. 2014;124:1896-8. doi:10.1172/JCI75801.

Inui M, Martello G, Piccolo S. MicroRNA control of signal transduction. Nat Rev Mol Cell Biol. 2010;11:252-63. doi:10.1038/nrm2868.

Ismail N, Wang Y, Dakhlallah D, et al. Macrophage microvesicles induce macrophage differentiation and miR-223 transfer. Blood. 2013;121:984-95. doi:10.1182/

blood-2011-08-374793.

Jansen F, Yang X, Hoelscher M, et al. Endothelial microparticle-mediated transfer of MicroRNA-126 promotes vascular endothelial cell repair via SPRED1 and is abrogated in glucose-damaged endothelial microparticles. Circulation. 2013;128:2026-38. doi:10.1161/ CIRCULATIONAHA.113.001720.

Jay C, Nemunaitis J, Chen P, et al. miRNA profiling for diagnosis and prognosis of human cancer. DNA Cell Biol. 2007;26:293-300.

Jensen SG, Lamy P, Rasmussen MH, et al. Evaluation of two commercial global miRNA expression profiling platforms for detection of less abundant miRNAs. BMC Genomics. 2011;12:435. doi: 10.1186/1471-2164-12-435.

Ji X, Takahashi R, Hiura Y, et al. Plasma miR-208 as a biomarker of myocardial injury. Clin Chem. 2009;55:1944-9. doi:10.1373/clinchem.2009.125310.

Jiang L, Schlesinger F, Davis CA, et al. Synthetic spike-in standards for RNA-seq experiments. Genome Res. 2011;21:1543-51. doi:10.1101/gr.121095.111.

Kaudewitz D, Lee R, Willeit P, et al. Impact of intravenous heparin on quantification of circulating microRNAs in patients with coronary artery disease. Thromb Haemost. 2013;110:609-15. doi: 10.1160/TH13-05-0368.

Kaudewitz D, Skroblin P, Bender LH, et al. Association of microRNAs and YRNAs with platelet function. Circ Res. 2016;118:420-32. doi:10.1161/CIRCRESAHA.114.305663.

Kirschner MB, Kao SC, Edelman JJ, et al. Haemolysis during sample preparation alters microRNA content of plasma. PLoS One. 2011;6:e24145. doi:10.1371/journal.pone.0024145.

Kroh EM, Parkin RK, Mitchell PS, et al. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods. 2010;50:298- 301. doi:10.1016/j.ymeth.2010.01.032.

Laffont B, Corduan A, Ple H, et al. Activated platelets can deliver mRNA regulatory Ago2*microRNA complexes to endothelial cells via microparticles. Blood. 2013;122:253-61. doi: 10.1182/blood-2013-03-492801.

Latorra D, Arar K, Hurley JM. Design considerations and effects of LNA in PCR primers. Mol Cell Probes. 2003;17:253-9.

Levin JD, Fiala D, Samala MF, et al. Position-dependent effects of locked nucleic acid (LNA) on DNA sequencing and PCR primers. Nucleic Acids Res. 2006;34:e142.

Li H, Guo L, Wu Q, et al. A comprehensive survey of maternal plasma miRNAs expression profiles using high-throughput sequencing. Clin Chim Acta. 2012;413:568-76. doi:10.1016/j. cca.2011.11.026.

Li J, Zhang Y, Liu Y, et al. Microvesicle-mediated transfer of microRNA-150 from monocytes to endothelial cells promotes angiogenesis. J Biol Chem. 2013;288:23586-96. doi:10.1074/jbc. M113.489302.

Li S, Zhu J, Zhang W, et al. Signature microRNA expression profile of essential hypertension and its novel link to human cytomegalovirus infection. Circulation. 2011;124:175-84. doi: 10.1161/ CIRCULATIONAHA.110.012237.

Linsen SE, De Wit E, Janssens G, et al. Limitations and possibilities of small RNA digital gene expression profiling. Nat Methods. 2009;6:474-6. doi:10.1038/nmeth0709-474.

Liu CG, Calin GA, Volinia S, et al. MicroRNA expression profiling using microarrays. Nat Protoc. 2008;3:563-78. doi:10.1038/nprot.2008.14.

Liu N, Olson EN. MicroRNA regulatory networks in cardiovascular development. Dev Cell. 2010;18:510-25. doi:10.1016/j.devcel.2010.03.010.

Loyer X, Vion AC, Tedgui A, et al. Microvesicles as cell-cell messengers in cardiovascular diseases. Circ Res. 2014;114:345-53. doi:10.1161/CIRCRESAHA.113.300858.

Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature. 2005;435:834-8.

Matkovich SJ, Hu Y, Dorn 2nd GW. Regulation of cardiac microRNAs by cardiac microRNAs. Circ Res. 2013;113:62-71. doi:10.1161/CIRCRESAHA.113.300975.

Mcdonald JS, Milosevic D, Reddi HV, et al. Analysis of circulating microRNA: preanalytical and analytical challenges. Clin Chem. 2011;57:833-40. doi:10.1373/clinchem.2010.157198.

Mendell JT, Olson EN. MicroRNAs in stress signaling and human disease. Cell. 2012;148:1172- 87. doi:10.1016/j.cell.2012.02.005.

Mestdagh P, Feys T, Bernard N, et al. High-throughput stem-loop RT-qPCR miRNA expression profiling using minute amounts of input RNA. Nucleic Acids Res. 2008;36:e143. doi:10.1093/ nar/gkn725.

Mestdagh P, Hartmann N, Baeriswyl L, et al. Evaluation of quantitative miRNA expression platforms in the microRNA quality control (miRQC) study. Nat Methods. 2014;11:809-15. doi:10.1038/nmeth.3014.

Metzker ML. Sequencing technologies - the next generation. Nat Rev Genet. 2010;11:31-46. doi:10.1038/nrg2626.

Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A. 2008;105:10513-8. doi:10.1073/pnas.0804549105.

Mittelbrunn M, Sanchez-Madrid F. Intercellular communication: diverse structures for exchange of genetic information. Nat Rev Mol Cell Biol. 2012;13:328-35. doi:10.1038/nrm3335.

Nielsen LB, Wang C, Sorensen K, et al. Circulating levels of microRNA from children with newly diagnosed type 1 diabetes and healthy controls: evidence that miR-25 associates to residual beta-cell function and glycaemic control during disease progression. Exp Diabetes Res. 2012;2012:896362. doi:10.1155/2012/896362.

Ozsolak F, Milos PM. RNA sequencing: advances, challenges and opportunities. Nat Rev Genet. 2011;12:87-98. doi:10.1038/nrg2934.

Pan Y, Liang H, Liu H, et al. Platelet-secreted microRNA-223 promotes endothelial cell apoptosis induced by advanced glycation end products via targeting the insulin-like growth factor 1 receptor. J Immunol. 2014;192:437-46. doi:10.4049/jimmunol.1301790.

Pinheiro LB, Coleman VA, Hindson CM, et al. Evaluation of a droplet digital polymerase chain reaction format for DNA copy number quantification. Anal Chem. 2012;84:1003-11. doi:10.1021/ac202578x.

Pritchard CC, Kroh E, Wood B, et al. Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies. Cancer Prev Res. 2012;5:492-7. doi:10.1158/1940-6207. CAPR-11-0370.

Sabin LR, Delas MJ, Hannon GJ. Dogma derailed: the many influences of RNA on the genome. Mol Cell. 2013;49:783-94. doi:10.1016/j.molcel.2013.02.010.

Sah S, Mccall MN, Eveleigh D, et al. Performance evaluation of commercial miRNA expression array platforms. BMC Res Notes. 2010;3:80. doi:10.1186/1756-0500-3-80.

Sorefan K, Pais H, Hah AE, et al. Reducing ligation bias of small RNAs in libraries for next generation sequencing. Silence. 2012;3:4. doi:10.1186/1758-907X-3-4.

Streets AM, Zhang X, Cao C, et al. Microfluidic single-cell whole-transcriptome sequencing. Proc Natl Acad Sci U S A. 2014;111:7048-53. doi:10.1073/pnas.1402030111.

Tabet F, Vickers KC, Cuesta Torres LF, et al. HDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cells. Nat Commun. 2014;5:3292. doi:10.1038/ncomms4292.

Tam S, De Borja R, Tsao MS, et al. Robust global microRNA expression profiling using next- generation sequencing technologies. Laboratory investigation. J Tech Met Pathol. 2014;94:350- 8. doi:10.1038/labinvest.2013.157.

Tang DT, Plessy C, Salimullah M, et al. Suppression of artifacts and barcode bias in high- throughput transcriptome analyses utilizing template switching. Nucleic Acids Res. 2013;41:e44. doi:10.1093/nar/gks1128.

Thery C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol. 2002;2:569-79.

Tijsen AJ, Creemers EE, Moerland PD, et al. MiR423-5p as a circulating biomarker for heart failure. Circ Res. 2010;106:1035-9. doi:10.1161/CIRCRESAHA.110.218297.

Tonge DP, Gant TW. What is normal? Next generation sequencing-driven analysis of the human circulating miRNAOme. BMC Mol Biol. 2016;17:4. doi:10.1186/s12867-016-0057-9.

Turchinovich A, Weiz L, Langheinz A, et al. Characterization of extracellular circulating microRNA. Nucleic Acids Res. 2011;39:7223-33. doi:10.1093/nar/gkr254.

Valadi H. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;9:654-9.

Van Balkom BW, De Jong OG, Smits M, et al. Endothelial cells require miR-214 to secrete exo- somes that suppress senescence and induce angiogenesis in human and mouse endothelial cells. Blood. 2013;121:3997-4006. doi:10.1182/blood-2013-02-478925.

Vickers KC, Palmisano BT, Shoucri BM, et al. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol. 2011;13:423-33. doi: 10.1038/ ncb2210.

Vogelstein B, Kinzler KW. Digital PCR. Proc Natl Acad Sci U S A. 1999;96:9236-41.

Vorwerk S, Ganter K, Cheng Y, et al. Microfluidic-based enzymatic on-chip labeling of miRNAs. New Biotechnol. 2008;25:142-9. doi:10.1016/j.nbt.2008.08.005.

Wagner J, Riwanto M, Besler C, et al. Characterization of levels and cellular transfer of circulating lipoprotein-bound microRNAs. Arterioscler Thromb Vasc Biol. 2013;33:1392-400. doi:10.1161/ATVBAHA.112.300741.

Wang C, Wan S, Yang T, et al. Increased serum microRNAs are closely associated with the presence of microvascular complications in type 2 diabetes mellitus. Sci Report. 2016;6:20032. doi: 10.1038/srep20032.

Wang H, Ach RA, Curry B. Direct and sensitive miRNA profiling from low-input total RNA. RNA. 2007;13:151-9.

Wang K, Zhang S, Marzolf B, et al. Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci U S A. 2009;106:4402-7. doi:10.1073/pnas.0813371106.

Wang K, Zhang S, Weber J, et al. Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Res. 2010;38:7248-59. doi:10.1093/nar/gkq601.

Wang X, Huang W, Liu G, et al. Cardiomyocytes mediate anti-angiogenesis in type 2 diabetic rats through the exosomal transfer of miR-320 into endothelial cells. J Mol Cell Cardiol. 2014;74:139-50. doi:10.1016/j.yjmcc.2014.05.001.

Widera C, Gupta SK, Lorenzen JM, et al. Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome. J Mol Cell Cardiol. 2011;51:872-5. doi:10.1016/j. yjmcc.2011.07.011.

Willeit P, Zampetaki A, Dudek K, et al. Circulating microRNAs as novel biomarkers for platelet activation. Circ Res. 2013;112:595-600. doi:10.1161/CIRCRESAHA.111.300539.

Willems M, Moshage H, Nevens F, et al. Plasma collected from heparinized blood is not suitable for HCV-RNA detection by conventional RT-PCR assay. J Virol Methods. 1993;42:127-30.

Yokota M, Tatsumi N, Nathalang O, et al. Effects of heparin on polymerase chain reaction for blood white cells. J Clin Lab Anal. 1999;13:133-40.

Zampetaki A, Kiechl S, Drozdov I, et al. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res. 2010;107:810-7. doi:10.1161/ CIRCRESAHA.110.226357.

Zampetaki A, Mayr M. MicroRNAs in vascular and metabolic disease. Circ Res. 2012;110:508- 22. doi: 10.1161/CIRCRESAHA.111.247445.

Zampetaki A, Willeit P, Burr S, et al. Angiogenic microRNAs linked to incidence and progression of diabetic retinopathy in type 1 diabetes. Diabetes. 2016;65:216-27. doi:10.2337/db15-0389. Epub 2015 Sep 22

Zampetaki A, Willeit P, Drozdov I, et al. Profiling of circulating microRNAs: from single biomarkers to re-wired networks. Cardiovasc Res. 2011;93:555-62. doi:10.1093/cvr/cvr266.

Zampetaki A, Willeit P, Tilling L, et al. Prospective study on circulating MicroRNAs and risk of myocardial infarction. J Am Coll Cardiol. 2012;60:290-9. doi:10.1016/j.jacc.2012.03.056.

Zardo G, Ciolfi A, Vian L, et al. Polycombs and microRNA-223 regulate human granulopoiesis by transcriptional control of target gene expression. Blood. 2012;119:4034-46. doi:10.1182/ blood-2011-08-371344.

Zernecke A, Bidzhekov K, Noels H, et al. Delivery of microRNA-126 by apoptotic bodies induces CXCL 12-dependent vascular protection. Sci Signal. 2009;2:ra81. doi:10.1126/

scisignal.2000610.

Zhang Y, Liu D, Chen X, et al. Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol Cell. 2010;39:133-44. doi:10.1016/j.molcel.2010.06.010.

Zisoulis DG, Kai ZS, Chang RK, et al. Autoregulation of microRNA biogenesis by let-7 and Argonaute. Nature. 2012;486:541-4. doi:10.1038/nature11134.

Zook JM, Samarov D, Mcdaniel J, et al. Synthetic spike-in standards improve run-specific systematic error analysis for DNA and RNA sequencing. PLoS One. 2012;7:e41356. doi:10.1371/ journal.pone.0041356.

 
Source
< Prev   CONTENTS   Source